HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation.

Abstract
Here we report the design, synthesis and biological evaluation of surface-modified silica nanoparticles (SNP) for the delivery of camptothecin (CPT). Drug has been covalently linked to the nanoparticle through an ester bond with the 20-hydroxy moiety, in order to stabilize its lactone ring and to avoid unspecific release of the drug. The obtained material is highly stable in plasma, with low release of the cargo at physiological pH. Cell internalization and in vitro efficacy assays demonstrated that nanoparticles carrying CPT (SNP-CPT) entered cells via endocytosis and the intracellular release of the cargo induced cell death with half maximal inhibitory concentration (IC₅₀) values and cell cycle distribution profiles similar to those observed for the naked drug. Further, in vivo biodistribution, therapeutic efficacy and biocompatibility of the SNP-CPT were evaluated in human colorectal cancer xenografts using in vivo fluorescence or bioluminescence optical imaging. In vivo tumor-accumulation and whole-body tissue distribution were carried out based on the acquisition of fluorescence emission of a fluorophore (Cy5.5) conjugated to the SNP-CPT, as well as by HPLC quantification of tissue CPT levels. The results showed that, although SNP-CPT tended to accumulate in organs of the reticulo-endothelial system, nanoparticles boost CPT concentration in tumor vs administration of the free drug. Accordingly, SNP-CPT treatment delayed the growth of subcutaneous tumors while significantly reducing the systemic toxicity associated with CPT administration. These results indicate that the SNP-CPT could be used as a robust drug delivery system for antitumoral treatments based on CPT.
AuthorsPablo Botella, Ibane Abasolo, Yolanda Fernández, Carlos Muniesa, Sonia Miranda, Manuel Quesada, Jorge Ruiz, Simó Schwartz Jr, Avelino Corma
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 156 Issue 2 Pg. 246-57 (Dec 10 2011) ISSN: 1873-4995 [Electronic] Netherlands
PMID21756949 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier B.V. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Silicon Dioxide
  • Camptothecin
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage, pharmacokinetics, therapeutic use)
  • Camptothecin (administration & dosage, pharmacokinetics, therapeutic use)
  • Cell Line, Tumor
  • Colorectal Neoplasms (drug therapy, pathology)
  • Humans
  • Mice
  • Models, Molecular
  • Nanoparticles (chemistry, ultrastructure)
  • Silicon Dioxide (chemistry)
  • Surface Properties
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: